A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults

Clinical trial NCT05703607 · TERMINATED

Trial details

NCT number: NCT05703607
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Shingles Herpes Zoster Infection Human

Start date: 2023-01-25
Primary completion: 2025-09-23
Enrollment: 484

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.